Horizon Therapeutics Limited was set up on Tuesday the 20th of December 2011. Their current partial address is Dublin, and the company status is Normal. The company's current directors have been the director of 4 other Irish companies between them; 1 of which is now closed. Horizon Therapeutics Limited has 1 shareholder. This Irish company shares its Eircode with at least 3 other companies.
| Company Name: | Horizon Therapeutics Limited |
| Company Status: | NORMAL |
| Company Address: | Pottery Road, Dún Laoghaire, Dublin |
| Telephone: | +353 (0)1 411 42 |
| Website: | www.horizonpharma.com |
| Key Executive: | Mr Greene |
| Company Size: | Log-In To View |
| Disclaimer | Other Details |
|---|---|
| Please note the contact details displayed above are collected from a variety of public sources and are appended to this report for your convenience. As they are non-CRO data, we can not vouch for their accuracy or timeliness. To update contact details on this company simply email us. | |
Mr Greene is a Company Director of Horizon Therapeutics Limited since 2023 and a listed Director of 3 other companies.
Generate a B2B Marketing List with ease and grow your business. Identify key decision makers and pre-qualified new prospects for your sales and business development teams.
Similar Companies - Create a marketing list of similar companies
The latest documents filed with the Companies Registration Office for Horizon Therapeutics Limited (which can include the Account Details) are listed below.
| CRO Document | Effective Date | Received By CRO | View Now | |
|---|---|---|---|---|
| Form B2: Change of Company Registered Office Address | 20/12/2024 | 14/01/2025 | Join Up | |
| SAP206 DECLARATION | 20/12/2024 | 20/12/2024 | Join Up | |
| Form G1 Special Resolution - General | 20/12/2024 | 20/12/2024 | Join Up | |
| Form B1C - Annual Return General | 30/09/2024 | 24/11/2024 | Join Up | |
| FINANCIAL STATEMENT | 30/09/2024 | 24/11/2024 | Join Up | |
| THIS COMPANY HAS 318 OTHER DOCS » | ||||
View CRO company documents and company reports any Irish company or business with ease.
View the Latest Credit Report and Credit Limit on Horizon Therapeutics Limited.
| Company Status: | Normal |
| Latest Credit Movement: |  |
| Date of Last Movement: | 10/02/2025 |
| Latest Accounts Filed: | 24/11/2024 |
| Report Based on Accounts: | 31/12/2023 |
| Next Set of Accounts Due: | 30/09/2025 |
| Overdue: | No |
| Credit Score: | Join-Up to View |
To View the latest Credit Rating or Credit Limit on Horizon Therapeutics Limited simply click 'Log-In' or 'Join-Up' below.
Vision-net Credit Scores save your business the time and cost of chasing slow payers. Evaluate risk at client application stage or run continuous credit checks on your full customer base.
Satisfy due diligence requirements on Horizon Therapeutics Limited in one single 'time-saving' search. Run full background checks for Fitness and Probity on the directors of Horizon Therapeutics Limited and Anti-Money Laundering checks (AML checks) on Horizon Therapeutics Limited
| Company Type: | LTD - Private Company Limited By Shares |
| Number of Shareholders: | 1 |
Log-in now to run Due Diligence checks and Compliance checks on Horizon Therapeutics Limited or click Join-up to get started.
Background check Companies, Sole Traders or Individuals and minimise your spend with more efficient Anti-Money Laundering checks and reports.
More people choose Vision-net over any other search service... ask us why?
10/03/2025
As businesses navigate ongoing cost and labour pressures, the latest data on commercial judgments highlights both the challenges and opportunities for financial resilience across Ireland.
03/03/2025
We are thrilled to announce that CRIF has officially obtained the Great Place to Work certification in multiple countries, marking an important achievement for our company.
24/02/2025
KYC and client screening is now even easier! Save time, reduce paperwork, and boost efficiency with our new service.
10/02/2025
To date in 2025, Ireland currently has over 730,000 Company Directors, reflecting the complexity of the nation's corporate landscape.
